Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology.
Relationships Between Retinal Axonal and Neuronal Measures and Global Central Nervous System Pathology in Multiple Sclerosis.
Strategies for myelin regeneration: lessons learned from development.
Association between pathological and MRI findings in multiple sclerosis.
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis.
High-dose cyclophosphamide in the treatment of multiple sclerosis.
Ongoing Oxidative Stress Causes Subclinical Neuronal Dysfunction in the Recovery Phase of EAE.
Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer.
Effects of the Anti-Multiple Sclerosis Immunomodulator Laquinimod on Anxiety and Depression in Rodent Behavioral Models.
The role of microbiome in central nervous system disorders.
HLA-DRB1-DQB1 Haplotypes Confer Susceptibility and Resistance to Multiple Sclerosis in Sardinia.
Comparison of a 1.5T standard vs. 3T optimized protocols in multiple sclerosis patients.
Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients.
Melatonin pathway genes are associated with progressive subtypes and disability status in multiple sclerosis among Finnish patients.
Humoral immune response to influenza vaccine in natalizumab-treated MS patients.
Effect of Glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab.
B-Cell Depletion Abrogates T Cell-Mediated Demyelination in an Antibody-Nondependent Common Marmoset Experimental Autoimmune Encephalomyelitis Model.
Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models.
Disease Suppression Persists With Ozanimod at 72 Weeks in MS
Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses.
Medication withdrawal in relapsing-remitting multiple sclerosis: why not?
Obstructive sleep apnea and fatigue in patients with multiple sclerosis.
IgM antibody identifies good candidates for natalizumab
Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis.
[2012: Update on diagnosis and treatment of multiple sclerosis].

Pages